Relation of hepatic steatosis to atherogenic dyslipidemia

American Journal of Cardiology

Volumn 112, Issue 10, 2013, Pages 1599-1604

  Makadia, Sunal S ^a   Blaha, Michael ^a   Keenan, Tanya ^b   Ndumele, Chiadi ^a   Jones, Steven ^a   Defilippis, Andrew ^c   Martin, Seth ^a   Kohli, Payal ^d   Conceicao, Raquel ^e   Carvalho, Jose ^e   Nasir, Khurram ^f   Blumenthal, Roger ^a   Santos, Raul D ^e,g  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^f Center for Prevention and Wellness   (United States)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROGENIC DYSLIPIDEMIA; BODY MASS; BRAZIL; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ECHOGRAPHY; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; BODY MASS INDEX; BRAZIL; DYSLIPIDEMIAS; FATTY LIVER; FEMALE; HUMANS; INCIDENCE; LIPIDS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84887022631     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.08.001     Document Type: Article

References (26)

1. M. Adiels, M. Taskinen, C. Packard, M. Caslake, A. Soro-Paavonen, J. Westerbacka, S. Vehkavaara, A. Häkkinen, S. Olofsson, H. Yki-Järvinen, and J. Borén Overproduction of large VLDL particles is driven by increased liver fat content in man Diabetologia 49 2006 755 765
2. G.J. Blake, J.D. Otvos, N. Rifai, and P.M. Ridker Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women Circulation 106 2002 1930 1937
3. K.K. Berneis, and R.M. Krauss Metabolic origins and clinical significance of LDL heterogeneity J Lipid Res 43 2002 1363 1379
4. W.C. Cromwell, and J.D. Otvos Low-density lipoprotein particle number and risk for cardiovascular disease Curr Atheroscler Rep 6 2004 381 387
5. C.D. Gardner, S.P. Fortmann, and R.M. Krauss Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women J Am Med Assoc 276 1996 875 881
6. M. Blaha, R. Blumenthal, E. Brinton, and T. Jacobson The importance of non-HDL cholesterol reporting in lipid management J Clin Lipidol 2 2008 267 273
7. D. Perloff, C. Grim, J. Flack, E.D. Frohlich, M. Hill, M. McDonald, and B.Z. Morgenstern Human blood pressure determination by sphygmomanometry Circulation 88 1993 2460 2470
8. K. Bush, D.R. Kivlahan, M.B. McDonell, S.D. Fihn, and K.A. Bradley The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test Arch Intern Med 158 1998 1789 1795
9. C.L. Craig, A.L. Marshall, M. Sjöström, A.E. Bauman, M.L. Booth, B.E. Ainsworth, M. Pratt, U. Ekelund, A. Yngve, J.F. Sallis, and P. Oja International physical activity questionnaire: 12-country reliability and validity Med Sci Sports Exerc 35 2003 1381 1395
10. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
11. A.E. Joseph, S.H. Saverymuttu, S. al-Sam, M.G. Cook, and J.D. Maxwell Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease Clin Radiol 43 1991 26 31
12. S. Saadeh, Z.M. Younossi, E.M. Remer, T. Gramlich, J.P. Ong, M. Hurley, K.D. Mullen, J.N. Cooper, and M.J. Sheridan The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 2002 745 750
13. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, and S.C. Smith Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
14. M.R. Salazar, H.A. Carbajal, W.G. Espeche, C.E. Leiva Sisnieguez, E. Balbín, C.A. Dulbecco, M. Aizpurúa, A.G. Marillet, and G.M. Reaven Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women Am J Cardiol 109 2012 1749 1753
15. A. Kotronen, and H. Yki-Jarvinen Fatty liver: a novel component of the metabolic syndrome Arterioscler Thromb Vase Biol 28 2008 27 38
16. C.E. Ndumele, K. Nasir, R.D. Conceiçao, J.A. Carvalho, R.S. Blumenthal, and R.D. Santos Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation Arterioscler Thromb Vasc Biol 31 2011 1927 1932
17. G. Targher, L. Bertolini, F. Poli, S. Rodella, L. Scala, R. Tessari, L. Zenari, and G. Falezza Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients Diabetes 54 2005 3541 3546
18. F.G.S. Toledo, A.D. Sniderman, and D.E. Kelley Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes Diabetes Care 29 2006 1845 1850
19. D. Chan, G. Watts, S. Gan, A. Wong, E. Ooi, and H. Barrett Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoportein-apolipoprotein B-100 in obesity Arterioscler Thromb Vasc Biol 30 2010 1043 1050
20. M. Adiels, M.R. Taskinen, and J. Boren Fatty liver, insulin resistance, and dyslipidemia Curr Diab Rep 8 2008 60 64
21. A. Zambon, J.E. Hokanson, B.G. Brown, and J.D. Brunzell Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density Circulation 99 1999 1959 1964
22. S. Rashid, T. Watanabe, T. Sakaue, and G.F. Lewis Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity Clin Biochem 36 2003 421 429
23. A. Sniderman, P. Couture, and J. de Graaf Diagnosis and treatment of apolipoprotein B dyslipoproteinemias Nat Rev Endocrinol 6 2010 335 346
24. J.D. Browning, and J.D. Horton Molecular mediators of hepatic steatosis and liver injury J Clin Invest 114 2004 147 152
25. K. Hosoyamada, H. Uto, Y. Imamura, Y. Hiramine, E. Toyokura, Y. Hidaka, T. Kuwahara, K. Kusano, K. Saito, M. Oketani, A. Ido, and H. Tsubouchi Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol Diabetol Metab Syndr 4 2012 34
26. A.P. DeFilippis, M.J. Blaha, S.S. Martin, R.M. Reed, S.R. Jones, K. Nasir, R.S. Blumenthal, and M.J. Budoff Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis Atherosclerosis 227 2013 429 436